ReviewCurrent pharmaceutical design2017

2-Hydroxypropyl-β-cyclodextrins and the Blood-Brain Barrier: Considerations for Niemann-Pick Disease Type C1.

Pericles CaliasPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.